Lytenava Injection
Product Images NDC 82491-025

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lytenava (NDC 82491-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Outlook Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Vial Label (Lytenava 4)

Vial Label (Lytenava 4)
Label for LYTENAVA (bevacizumab-vikg) injection, 1.25 mg/0.05 mL (25 mg/mL), intravitreal dosage form. The label indicates Rx only, includes a barcode, and states it is manufactured by Outlook Therapeutics, Inc. The NDC is 82491-025-10.*
FDA Label Image

Carton Label (Lytenava 5)

Carton Label (Lytenava 5)
Packaging label for LYTENAVA (bevacizumab-vikg) injection, 1.25 mg (0.05 mL of 25 mg/mL), for intravitreal use. The label states it is a single-dose vial and includes storage instructions to refrigerate at 2°C to 8°C (36°F to 46°F) and to avoid freezing. Manufactured by Outlook Therapeutics, Inc. with the NDC 82491-025. The label lists active and inactive ingredients and carries a barcode and QR code.*
FDA Label Image

Figure 1 (Lytenava Figure 1)

Figure 1 (Lytenava Figure 1)
A line graph comparing mean BCVA (best corrected visual acuity) change from baseline over 12 study months for LYTENAVA 1.25 mg versus Ranibizumab 0.5 mg. The x-axis shows study months from 0 to 12, and the y-axis shows mean ± SE BCVA change. The graph depicts higher mean BCVA improvement over time with LYTENAVA compared to Ranibizumab.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.